CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating activities
Net loss	$ (46)	$ (23)
Adjustments to reconcile net income to net cash provided by operating activities:
Vehicle depreciation	353	331
Gain on sale of vehicles, net	0	(39)
Non-vehicle related depreciation and amortization	34	32
Amortization of debt financing fees	11	16
Net change in assets and liabilities, excluding the impact of acquisitions and dispositions:
Receivables	(57)	(28)
Income taxes and deferred income taxes	(21)	0
Accounts payable and other current liabilities	(35)	(65)
Other, net	61	29
Net cash provided by operating activities	300	253
Investing activities
Property and equipment additions	(21)	(20)
Proceeds received on asset sales	4	3
Net assets acquired, net of cash acquired	(476)	0
Other, net	26	(1)
Net cash used in investing activities exclusive of vehicle programs	(467)	(18)
Vehicle programs:
Increase in program cash	(24)	(39)
Investment in vehicles	(3,111)	(3,053)
Proceeds received on disposition of vehicles	2,394	2,143
Net cash used in investing activities of vehicle programs	(741)	(949)
Net cash used in investing activities	(1,208)	(967)
Financing activities
Proceeds from long-term borrowings	1,225	624
Principal payments on long-term borrowings	(788)	(520)
Net change in short-term borrowings	(31)	(12)
Purchases of warrants	(28)	(13)
Proceeds from sale of call options	37	19
Debt financing fees	(10)	(8)
Other, net	2	0
Net cash provided by financing activities exclusive of vehicle programs	407	90
Vehicle programs:
Proceeds from borrowings	3,762	3,140
Payments on borrowings	(3,279)	(2,440)
Debt financing fees	(17)	(7)
Net cash provided by financing activities of vehicle programs	466	693
Net cash provided by financing activities	873	783
Effect of changes in exchange rates on cash and cash equivalents	(2)	3
Net increase (decrease) in cash and cash equivalents	(37)	72
Cash and cash equivalents, beginning of period	606	534
Cash and cash equivalents, end of period	$ 569	$ 606